A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)

Nguyen, Alain; Calmy, Alexandra; Delhumeau, Cecile; Mercier, Isabelle; Cavassini, Matthias; Mello, Aurelie F; Elzi, Luigia; Rauch, Andri; Bernasconi, Enos; Schmid, Patrick; Hirschel, Bernard (2011). A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study). AIDS, 25(12), pp. 1481-7. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/QAD.0b013e328348dab0

Full text not available from this repository. (Request a copy)

Efavirenz (EFV) causes neuropsychiatric side-effects and an unfavorable blood lipid profile. We investigated the effect of replacing EFV with raltegravir (RAL) on patient preference, daytime sleepiness, sleep quality, anxiety, and lipid levels.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Infectiology

UniBE Contributor:

Rauch, Andri

ISSN:

0269-9370

Publisher:

Lippincott Williams & Wilkins

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:24

Last Modified:

17 Mar 2015 21:03

Publisher DOI:

10.1097/QAD.0b013e328348dab0

PubMed ID:

21593661

Web of Science ID:

000292636300005

URI:

https://boris.unibe.ch/id/eprint/8268 (FactScience: 213784)

Actions (login required)

Edit item Edit item
Provide Feedback